Clinical Trial Update: PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) [NA]

View source ↗

Summary

PLATON, a platform for analyzing targetable tumor mutations, completed its pilot study evaluating its utility across hepatocellular carcinoma, cholangiocarcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Esophageal Cancer
• Gallbladder Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Hepatocellular Cancer, Cholangiocarcinoma | NA | Status: COMPLETED